Led by Konrad Wallerstein (Pharma Focus LLC) and Lloyd Morgan (Adelphi), the Adelphi Focus team brings broad experience of successfully addressing issues of price and reimbursement relating to all aspects of access throughout a product's lifecycle.
We offer clients strategic vision, practical tactics and help with the implementation of our recommendations on accessing healthcare markets.
